Literature DB >> 31829025

MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4.

Z Cui1, Q L Liu1, S Q Sun2, K Jiao1, D R Liu1, X C Zhou3, L Huang3.   

Abstract

Oral squamous cell carcinoma (OSCC) is still a leading cause of cancer death owing to distant metastasis, which is largely facilitated by tumor angiogenesis. MicroRNA (miR)-378a-5p and Kallikrein-related peptidase 4 (KLK4) participate in tumorigenesis and tumor metastasis according to previous studies, yet the exact role they play in tumor angiogenesis remains poorly understood. The aim of the present study is to investigate the effect of miR-378a-5p and KLK4 on angiogenesis of OSCC. MTT assay showed that the expression level of miR-378a-5p was negatively correlated with the proliferation of OSCC cells. ELISA and Western blot assay showed that down-regulation of miR-378a-5p promotes VEGF expression. Tube formation and in vivo chicken chorioallantoic membrane (CAM) assay showed that inhibition of miR-378a-5p reduced tube formation of human umbilical vein endothelial cells (HUVECs) and newly formed microvessel. On the contrary, over-expression of KLK4 enhanced angiogenesis of OSCC cells with increased VEGF expression, tube formation activity of HUVECs and newly formed microvessel. Moreover, the dual-luciferase assay validated that KLK4 was a target gene of miR-378a-5p. MiR-378a-5p silencing induced tube formation was suppressed by the downregulation of KLK4. Besides, the activation of Wnt/β-catenin signaling pathway in miR-378a-5p antagomir transfected cells was also blocked by the KLK4 shRNA. To sum up, our study suggests that miR-378a-5p suppressed angiogenesis of OSCC at least partly by the regulation of KLK4.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31829025     DOI: 10.4149/neo_2019_190306N191

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  10 in total

1.  Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer.

Authors:  Weiwei Gong; Caixia Zhu; Yueyang Liu; Alexander Muckenhuber; Holger Bronger; Andreas Scorilas; Marion Kiechle; Julia Dorn; Viktor Magdolen; Tobias Dreyer
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 2.  Research progress and clinical application prospects of miRNAs in oral cancer.

Authors:  Long Xing; Zhenghu Feng; Hongbing Nie; Meitian Liu; Yali Liu; Xiaohua Zhang; Haijing Zhou
Journal:  Mol Biol Rep       Date:  2022-06-20       Impact factor: 2.316

3.  Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.

Authors:  Meijuan Cai; Zhichao Zheng; Zhibao Bai; Kexiong Ouyang; Qiuyu Wu; Shaofen Xu; Lihuan Huang; Yingtong Jiang; Lijing Wang; Jie Gao; Janak L Pathak; Lihong Wu
Journal:  BMC Cancer       Date:  2022-05-11       Impact factor: 4.638

4.  DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma.

Authors:  Yumeng Zhu; Xiaojun Liu; Yang Wang; Yongbo Pan; Xiaoqi Han; Bo Peng; Xu Zhang; Shaoxi Niu; He Wang; Qinong Ye; Yinmin Gu; Shan Gao
Journal:  Cell Death Dis       Date:  2022-05-13       Impact factor: 9.685

5.  Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c.

Authors:  Ming-Yu Lien; An-Chen Chang; Hsiao-Chi Tsai; Ming-Hsui Tsai; Chun-Hung Hua; Shih-Ping Cheng; Shih-Wei Wang; Chih-Hsin Tang
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

6.  Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway.

Authors:  Cuiju Wang; Yalei Lv; Ziyue Sha; Jingjing Zhang; Jianhua Wu; Yixin Qi; Zhanjun Guo
Journal:  J Hepatocell Carcinoma       Date:  2021-12-29

7.  LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression.

Authors:  Xin Wang; Hongtao Liu; Qing Zhang; Xueying Zhang; Yue Qin; Guangzhao Zhu; Jinghan Dang; Feng Wang; Xiangxiang Yang; Ruitai Fan
Journal:  Int J Oncol       Date:  2021-09-17       Impact factor: 5.650

8.  MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.

Authors:  Ana Elisa Valencise Quaglio; Felipe Jose Santaella; Maria Aparecida Marchesan Rodrigues; Ligia Yukie Sassaki; Luiz Claudio Di Stasi
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

9.  LncRNA CYTOR drives L-OHP resistance and facilitates the epithelial-mesenchymal transition of colon carcinoma cells via modulating miR-378a-5p/SERPINE1.

Authors:  Jialin Yang; Qin Ma; Mingming Zhang; Wanfu Zhang
Journal:  Cell Cycle       Date:  2021-07-05       Impact factor: 5.173

10.  YEATS domain-containing 2 (YEATS2), targeted by microRNA miR-378a-5p, regulates growth and metastasis in head and neck squamous cell carcinoma.

Authors:  Tong Sha; Jia Li; Shiqun Sun; Jianing Li; Xuetao Zhao; Zehua Li; Zhi Cui
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.